SSA
CORZ

Schonfeld Strategic Advisors’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-165,785
Closed -$1.36M – 3244
2022
Q1 		$1.36M Buy
+165,785
New +$1.46M 0.01% 861
2021
Q4 		– Sell
-184,100
Closed -$1.86M – 2729
2021
Q3 		$1.86M Buy
+184,100
New +$1.85M 0.02% 739

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Schonfeld Strategic Advisors's CORZ Position: Q2 2022 in Review

Schonfeld Strategic Advisors sold out of Core Scientific, Inc. Common Stock (CORZ) in Q2 2022, closing a stake of 165,785 shares — an estimated $1.36M sold.

Schonfeld Strategic Advisors first reported a position in CORZ in Q3 2021 and held it in 2 quarters. The position peaked at $1.86M in Q3 2021. 141 funds tracked by Wall St. Rank hold CORZ as of Q2 2022.

  • Schonfeld Strategic Advisors reported no remaining Core Scientific, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 165,785 Core Scientific, Inc. Common Stock shares in Q2 2022, an estimated $1.36M.
  • Schonfeld Strategic Advisors first reported a position in Core Scientific, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Core Scientific, Inc. Common Stock position peaked at $1.86M in Q3 2021.
  • 141 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.